Zhejiang Taimei Medical Technology Co., Ltd.
Zhejiang Taimei Medical Technology Co., Ltd. provides digital operation platform for the biopharma industry in China. The company offers TrialOS, a drug digital cooperation platform that connects the cycle of hospitals, pharmaceutical companies, third-party providers, regulatory authorities, patients, and other industry stakeholders; PharmaOS, a pharmaceutical digital marketing platform; and Ente… Read more
Zhejiang Taimei Medical Technology Co., Ltd. (A2V) - Total Liabilities
Latest total liabilities as of June 2025: €302.10 Million EUR
Based on the latest financial reports, Zhejiang Taimei Medical Technology Co., Ltd. (A2V) has total liabilities worth €302.10 Million EUR as of June 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Zhejiang Taimei Medical Technology Co., Ltd. - Total Liabilities Trend (2021–2024)
This chart illustrates how Zhejiang Taimei Medical Technology Co., Ltd.'s total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Zhejiang Taimei Medical Technology Co., Ltd. Competitors by Total Liabilities
The table below lists competitors of Zhejiang Taimei Medical Technology Co., Ltd. ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Leo Lithium Limited
PINK:LLLAF
|
USA | $8.07 Million |
|
Marmaris Altinyunus Turistik Tesisleri AS
IS:MAALT
|
Turkey | TL759.63 Million |
|
Plastron Precision Co Ltd
TWO:6185
|
Taiwan | NT$345.06 Million |
|
CrystalGenomics Inc
KQ:083790
|
Korea | ₩124.24 Billion |
|
Ramayana Lestari Sentosa Tbk
JK:RALS
|
Indonesia | Rp988.95 Billion |
|
EURO PRATIK SALES LIMITED
NSE:EUROPRATIK
|
India | ₹556.67 Million |
|
Thai Nguyen International Hospital JSC
VN:TNH
|
Vietnam | ₫1.12 Trillion |
Liability Composition Analysis (2021–2024)
This chart breaks down Zhejiang Taimei Medical Technology Co., Ltd.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 5.66 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.26 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.20 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Zhejiang Taimei Medical Technology Co., Ltd.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Zhejiang Taimei Medical Technology Co., Ltd. (2021–2024)
The table below shows the annual total liabilities of Zhejiang Taimei Medical Technology Co., Ltd. from 2021 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | €348.62 Million | -13.40% |
| 2023-12-31 | €402.56 Million | -8.92% |
| 2022-12-31 | €441.97 Million | +12.25% |
| 2021-12-31 | €393.75 Million | -- |